FDA Issued Warning About Asthma Drug Xolair. Citing reports of severe, potentially fatal allergic reactions, the U.S. Food and Drug Administration (FDA) has issued a new warning about omalizumab, an asthma drug marketed by Genentech as Xolair. The agency has requested a “black box” warning be added to the product’s label reflecting … [Read more...] about FDA Issues New Xolair Warning
Government Ordered Label Warnings For An Asthma Drug. The government ordered stronger label warnings for an injected asthma medication Wednesday because of reports some patients taking the drug, marketed as Xolair, had suffered a delayed and potentially life-threatening reaction known as anaphylaxis. A patient experiencing … [Read more...] about FDA orders stronger asthma drug warning
Asthma Drug Advair Get Label Alerts. The asthma medication Advair and a related drug will bear stronger warnings of an increased risk of death associated with one of their ingredients. The revised warnings apply to Advair and Serevent, Food and Drug Administration spokeswoman Laura Alvey said Monday. Advair is GlaxoSmithKline's … [Read more...] about Advair Get Label Alerts
Asthma Drug Side Effects. Jim and Star Chavez didn't think twice when their doctor prescribed Advair for their son Ethan. Inhaled daily, Advair was supposed to prevent his occasional mild asthma attacks. Instead, as CBS News Correspondent Sharyl Attkisson reports, shortly after he started using Advair, Ethan collapsed. "He was … [Read more...] about Does Asthma Drug Trigger Attacks?
Asthma Drug Potential Risks. US drugs industry regulators yesterday said they would slap warning labels on one of GlaxoSmithKline's most established asthma treatments after about 45 African-American patients suffered severe attacks, some causing death, during a 28-week routine test. London-listed GSK said it had agreed … [Read more...] about Glaxo Asthma Drug Warning